{
    "2019-02-20": [
        [
            {
                "time": "2019-02-20",
                "original_text": "Better Buy: Pfizer vs. Eli Lilly",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Eli Lilly",
                        "Better Buy"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-02-20",
                "original_text": "After Hours Most Active for Feb 20, 2019: PFE, ET, TAHO, PRQR, TWTR, XEL, SIRI, QCOM, NWL, XOM, T, AMED",
                "features": {
                    "keywords": [
                        "Most Active",
                        "PFE",
                        "TWTR",
                        "XOM"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "diverse"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-20",
                "original_text": "Market Recap for Wednesday February 20",
                "features": {
                    "keywords": [
                        "Market Recap"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-02-20",
                "original_text": "Pfizer & Lilly's Pain Candidate Succeeds in Back Pain Study",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Lilly",
                        "Pain Candidate",
                        "Back Pain Study",
                        "Succeeds"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}